World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Uncategorized

GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services

Cision PR Newswire by Cision PR Newswire
February 10, 2026
in Uncategorized
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

YONGIN, South Korea, Feb. 10, 2026 /PRNewswire/ — GCCL Co., Ltd. (GCCL), a data-driven clinical trial services provider, and Medicover Integrated Clinical Services (MICS), part of Medicover, an international healthcare and diagnostic services company, have signed a Memorandum of Understanding (MOU) to collaborate on multinational clinical trial services.

Through this MOU, the two companies aim to establish a collaborative framework covering Europe, the United States, and the Asia-Pacific (APAC) region. By leveraging their respective experience in clinical trial operations and client communications across key regions, the partnership seeks to enhance cross-regional communication efficiency and improve operational stability in global clinical trial projects.

Key areas of collaboration under the MOU include clinical trial operations and sample analysis collaboration across regions; project management support and coordinated client communication by region; joint marketing collaboration; joint client development and market expansion; and the enhancement of service competitiveness through test item alignment and improved analytical efficiency.

By combining MICS’s extensive experience and network in Europe and the U.S. with GCCL’s specialized analytical capabilities and project management expertise in the APAC region, the two companies expect to offer a more seamlessly connected and optimized environment for multinational clinical trial operations and analysis.

“This agreement represents an important opportunity to effectively combine the expertise and customer bases of both organizations and further strengthen the global clinical trial ecosystem,” said Łukasz Hubisz, General Manager of MICS. “Through our collaboration with GCCL, we aim to strengthen communication with clients in Asia and support the smoother execution of global clinical trial projects.”

Kwan Goo Cho, CEO of GCCL, added, “This partnership marks an important first step in reinforcing clinical collaboration between Europe and Asia. Through our strategic cooperation with MICS, we aim to set new standards for global clinical trial execution and deliver meaningful analytical outcomes for our clients.”

About GCCL

GCCL, a subsidiary of the GC Group, is a leading total solution provider for clinical trial sample analysis, offering an integrated “one-stop lab solution” with central, bioanalysis, and BSL-3 labs under a single system. With tailored solutions, GCCL delivers precise and efficient analytical services across all phases of clinical trials, solidifying its position as a trusted partner in new drug development. Leveraging advanced platforms and LIMS, the company supports partners across Asia and beyond with customized and compliant solutions. In recognition of its leadership, GCCL recently received Frost & Sullivan’s 2025 Best Practices Customer Value Leadership Award in the Asia-Pacific clinical sample analysis services industry. For more details, visit: www.eng.gccl.co.kr.

About Medicover Integrated Clinical Services (MICS)

Medicover Integrated Clinical Services (MICS) is a strategic business organization of Medicover Diagnostic Services that supports the development and commercialization of innovative therapies and medicines. MICS focuses on clinical applications and clients from pharmaceuticals, diagnostics, biopharma, biotech, medtech and contract research organizations (CROs). MICS’ activities are organized along discrete service lines: Central Laboratory Services, Site Management Organization, Precision Medicine. MICS has been providing bespoke services to clients and their patients for over 20 years, making strategic use of Medicover assets, including laboratories with state-of-the-art diagnostic equipment, medical clinics and hospitals, as well as the vast expertise and enthusiasm of a global workforce. For more details, visit:: Medicover MICS.

GC Biopharma Contacts (Media)

Sohee Kim
shkim20@gccorp.com

Yelin Jun
yelin@gccorp.com

Yoonjae Na
yjy6520@gccorp.com

GCCL Contacts (Media)

HyeYeon Woo
hywoo@gccorp.com

 

Cision View original content:https://www.prnewswire.com/news-releases/gccl-and-medicover-integrated-clinical-services-announce-strategic-collaboration-to-strengthen-multinational-clinical-trial-services-302683542.html

SOURCE GCCL

Cision PR Newswire

Cision PR Newswire

Related Posts

love around the world cultures

Love Around the World: How Different Cultures Define Romance

March 17, 2026
Oscars 2026 fashion

The Best Oscars 2026 Red Carpet Fashion Moments That Defined the Night

March 16, 2026
eating disorders

Eating Disorders in Women: What Is Really Going On and Where to Get Help

March 16, 2026
Mels Robins skin care

The Dermatologist Skincare Routine That Actually Works

March 16, 2026

Ulike Spring: Dare to Glow — Celebrating Confident and Aspirational Women

March 9, 2026

Wilentz, Goldman & Spitzer, P.A. Welcomes Former Presiding Judge Robert J. Mega to the Firm

March 9, 2026

Popular News

  • HTGC Investors Have Opportunity to Lead Hercules Capital, Inc. Securities Fraud Lawsuit

    0 shares
    Share 0 Tweet 0
  • Tamarack Resort Hosts Two Weekends of High-Energy RMSHA Races

    0 shares
    Share 0 Tweet 0
  • PSIX Investors Have Opportunity to Lead Power Solutions International, Inc. Securities Fraud Lawsuit

    0 shares
    Share 0 Tweet 0
  • LU Investors Have Opportunity to Lead Lufax Holding Ltd Securities Fraud Lawsuit First Filed by the Firm

    0 shares
    Share 0 Tweet 0
  • REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler